GSK shares fell more than 5% after U.S. health officials narrowed their recommendation of respiratory syncytial virus vaccines to a smaller age range and more at-risk patients.
Related Posts
Ericsson Shares Slump as Earnings Hit by Weakness Outside of Core Networks Business
- staff
- January 24, 2025
- 0
The company’s shares fell to the bottom of the Stoxx Europe 600 index as higher operating costs and weakness in some of its business units […]
How Security Teams Protect Top Executives
Big companies are hurrying to adjust security protocols for top executives after the killing of UnitedHealthcare’s CEO. Here’s how executive security teams approach the task.
BMW Recalls More Than 394,000 Vehicles Over Air-Bag Problem
The German premium carmaker is recalling the vehicles in the U.S. to fix potentially faulty air-bag inflaters that pose a risk of exploding.